NYSE · CALX

CALIX, Inc.

$36.00 +$0.23 (+0.64%) 1D After hours

Key Metrics

$2.28B
Market cap
67.34×
P/E · TTM
$1.06B
Revenue · TTM
$33.88M
Net income
EPS · TTM $0.51
Dividend yield
Free cash flow $109.13M
Beta · 1Y 0.90
EBITDA · TTM $70.21M
Gross margin 57.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    A material event was filed (Form 8-K).

    8-K - CALIX, INC (0001406666) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    From its Feb 20 high, the share price fell 37%.

    Peak close $55.61 on Feb 20; trough close $35.20 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -37%
  • Apr 22
    The stock moved -14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 22

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.28B
Enterprise value
Shares outstanding63.8M
52-wk range$34.26 – $71.22
Avg volume · 20D750.1K
Net cash
Book value / share$11.18
IndustryCommunications Services, Nec
ExchangeNYSE
About CALIX, Inc.
IPO dateMar 24, 2010
Employees1921

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E67.34
P/S2.15
P/FCF20.91
EV/EBITDA
EV/Sales
Graham №$11.36

Profitability

Gross 57.1%
Operating 4.9%
Net 3.2%
FCF 10.3%
ROE / ROIC 4.5% · 5.0%

Financial Health

Current ratio3.29
Quick ratio2.42
Debt / equity
Debt / EBITDA
Net cash
Working capital$408.70M

Cash Flow · TTM

Operating CF $132.38M
Capex −$23.24M
Free cash flow $109.13M
Buybacks $224.53M
Dividends paid
Shareholder yield 9.8%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

7.7
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$11.36 vs $36.00
Trades 3.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-28 · computed by TickerWolf from SEC filings